Long-read Sequencing And Genomics Trends Will Expand Market Potential

Published
28 Mar 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
US$2.11
34.6% undervalued intrinsic discount
15 Aug
US$1.38
Loading
1Y
-11.5%
7D
5.3%

Author's Valuation

US$2.1

34.6% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Increased 7.71%

Shared on24 Apr 25
Fair value Decreased 7.98%

AnalystConsensusTarget has increased shares outstanding growth rate from 0.1% to 0.1%.

Shared on17 Apr 25
Fair value Increased 3.65%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 10%

Shared on02 Apr 25
Fair value Decreased 1.72%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.